Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · IEX Real-Time Price · USD
4.110
+0.220 (5.66%)
At close: Mar 28, 2024, 4:00 PM
4.180
+0.070 (1.70%)
After-hours: Mar 28, 2024, 7:55 PM EDT

Vanda Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2004
Revenue
192.64254.38268.68248.17227.19193.12165.08146.02109.9350.16
Upgrade
Revenue Growth (YoY)
-24.27%-5.32%8.27%9.23%17.64%16.98%13.06%32.83%119.16%48.05%
Upgrade
Cost of Revenue
14.824.2825.6323.3624.4920.5117.8524.7123.461.58
Upgrade
Gross Profit
177.84230.1243.05224.8202.7172.61147.24121.3186.4648.57
Upgrade
Selling, General & Admin
112.88136.49124.05140.51129.74105.75123.8499.7984.5384.64
Upgrade
Research & Development
76.8285.7775.3655.5848.6543.5938.5529.1629.1519.23
Upgrade
Other Operating Expenses
2.091.521.481.481.511.531.7510.9312.97-75.36
Upgrade
Operating Expenses
191.8223.77200.89197.57179.89150.87164.14139.88126.6528.51
Upgrade
Operating Income
-13.956.3342.1727.2422.8121.74-16.9-18.57-40.1920.06
Upgrade
Other Expense / Income
-20.29-4.97-0.2-4.42-6.22-3.61-1.47-0.67-0.32-0.12
Upgrade
Pretax Income
6.3411.342.3631.6629.0325.35-15.43-17.91-39.8720.19
Upgrade
Income Tax
3.835.039.218.32-86.530.140.140.100
Upgrade
Net Income
2.516.2833.1523.34115.5525.21-15.57-18.01-39.8720.19
Upgrade
Net Income Growth
-60.02%-81.07%42.06%-79.80%358.40%-----
Upgrade
Shares Outstanding (Basic)
57565654535145434235
Upgrade
Shares Outstanding (Diluted)
58575755555345434237
Upgrade
Shares Change
1.01%0.11%3.14%0.63%3.40%18.58%2.96%2.84%15.16%20.87%
Upgrade
EPS (Basic)
0.040.110.600.432.170.50-0.35-0.41-0.940.58
Upgrade
EPS (Diluted)
0.040.110.580.422.110.48-0.35-0.41-0.940.55
Upgrade
EPS Growth
-63.64%-81.03%38.10%-80.09%339.58%-----
Upgrade
Free Cash Flow
12.4231.3163.6649.9844.934.62-3.65-9.519.92-82.32
Upgrade
Free Cash Flow Per Share
0.220.551.150.920.850.09-0.08-0.220.23-2.37
Upgrade
Gross Margin
92.32%90.45%90.46%90.59%89.22%89.38%89.19%83.08%78.66%96.84%
Upgrade
Operating Margin
-7.24%2.49%15.69%10.98%10.04%11.26%-10.24%-12.72%-36.56%40.00%
Upgrade
Profit Margin
1.30%2.47%12.34%9.40%50.86%13.05%-9.43%-12.33%-36.27%40.25%
Upgrade
Free Cash Flow Margin
6.45%12.31%23.69%20.14%19.78%2.39%-2.21%-6.51%9.03%-164.13%
Upgrade
Effective Tax Rate
60.42%44.47%21.74%26.28%-298.07%0.54%----
Upgrade
EBITDA
9.3514.0345.2134.5231.9228.3-12.45-6.04-26.3122.97
Upgrade
EBITDA Margin
4.85%5.52%16.82%13.91%14.05%14.66%-7.54%-4.14%-23.94%45.80%
Upgrade
Depreciation & Amortization
3.012.732.842.862.892.962.9811.8713.552.78
Upgrade
EBIT
6.3411.342.3631.6629.0325.35-15.43-17.91-39.8720.19
Upgrade
EBIT Margin
3.29%4.44%15.77%12.76%12.78%13.12%-9.35%-12.26%-36.27%40.25%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).